Drawing for OROCAN

USPTO serial 79332604

OROCAN

Reviewed by CopyMark Law Group

Reg. 7244881Status 700Registered
Filing date
Status date
Registration date
Dec 19, 2023
Examiner
LOBO, DEBORAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OROCAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Cannabis extracts for the food industry; cannabis extracts for use in the manufacture of cosmetics; cannabis extracts for use in the manufacture of pharmaceuticals; proteins for the food industry; proteins for use in the manufacture of food supplements; metallic soap for industrial purposes; herb extracts, other than essential oils, for use in the manufacture of cosmetics; plant extracts, other than essential oils, for use in the manufacture of cosmetics; biological preparations for use in industry and science other than for medical use; antioxidants for use in the manufacture of cosmetics; antioxidants for use in the manufacture of food supplements; antioxidants for use in the manufacture of food and beverages; antioxidants for use in the manufacture of pharmaceuticals; chemicals used in industry; chemical preparations for use in the food industry; chemical substances for preserving foodstuffs; chemical additives for food; plant extracts for the manufacture of pharmaceuticals; botanical extracts for use in making cosmetics; all of the foregoing goods that contain ingredients from cannabis are derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and any CBD in the goods is present in only trace amounts and derived from the mature stalks and sterilized seeds of hemp and does not contain THCACTIVE—
003Cosmetics for personal use; perfumery, essential oils; skin ointments for cosmetic use; aromatics, namely, essential oils; essential oils for aromatherapy use; oils for cosmetic purposes; essential oils for personal use; essential oils and aromatic extracts comprised of essential oils; essential oils for soothing the nerves; ethereal essences and oils; topical herbal extracts for cosmetic purposes; phytocosmetic preparations; hair lotion; cosmetic hair lotions; bath salts, not for medical purposes; dentifrices; non-medicated preparations for teeth and mouthcare, namely, mouthwashes and teeth whitening preparations; topical cannabis for cosmetic purposes; topical hemp extracts for cosmetic purposes; all of the foregoing goods that contain ingredients from cannabis or hemp are derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and any CBD in the goods is present in only trace amounts and derived from the mature stalks and sterilized seeds of hemp and does not contain THCACTIVE—
005Pharmaceuticals, namely, pharmaceutical preparations for use in the treatment of pain, nausea, insomnia, PTSD, cancer, seizures, anxiety, diabetes, colds and flu, muscle and joint pain, arthritis, antiviral inflammatory diseases, Covid 19; food supplements for human and veterinary use; medical preparations, namely, medical preparations for use in the treatment of pain, nausea, insomnia, PTSD, cancer, seizures, anxiety, diabetes, colds and flu, muscle and joint pain, arthritis, skin rashes, Covid 19, inflammatory diseases; veterinary preparations, namely, veterinary preparations for use in the treatment of pain, nausea, seizures, anxiety, muscle and joint pain, arthritis, skin rashes, antiviral inflammatory diseases, Covid 19 and dietary supplements; pharmaceuticals and natural remedies, namely, cough syrup, topical analgesics, medicated skin creams, natural remedies in the nature of herbal tinctures for medicinal use, medications for the treatment of muscles and joint pain, seizures, insomnia, nausea, antiviral inflammatory diseases, Covid 19; extracts made of medicinal plants for pharmaceutical and medicinal use; extracts of medicinal plants for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; antioxidants; foodstuffs and dietetic substances for medical or veterinary purposes; dietary supplements for humans; dietary supplements for animals; cannabis for medical purposes; hemp extracts for pharmaceutical purposes; medical plasters, materials for dressings; medical dressings; all of the foregoing goods that contain ingredients from cannabis or hemp are derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and any CBD in the goods is present in only trace amounts and derived from the mature stalks and sterilized seeds of hemp and does not contain THCACTIVE—
030Flowers or leaves for use as tea substitutes; preparations for making tea-based beverages; herbal infusions, not medicinal; aromatic preparations for making non-medicated infusions, namely, preparations made of leaves, aromatic roots and flowers; aromatic preparations for making non-medicated tisanes, namely, preparations made of leaves, aromatic roots and flowers; food flavorings, other than essential oils; substances imparting flavour for addition to food other than essential oils, namely, food flavorings; hemp-based food, namely, pasta made of hemp, hemp-based cereal bars, hemp flour, hemp tea; cereal preparations, namely, cereal bars, high protein cereal bars, cereal based energy bars, breakfast cereals, cereal based snack foods, processed cereal flakes; cereal-based snack food; cereal-based chips; processed seeds for use as a seasoning; processed hemp seeds for use as seasoning; all of the foregoing goods that contain ingredients from hemp are derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and any CBD in the goods is present in only trace amounts and derived from the mature stalks and sterilized seeds of hemp and does not contain THCACTIVE—
040custom manufacture of cannabis extracts, proteins, herbal extracts, plant extracts other than essential oils, biological preparations antioxidants, biological extracts, chemical substances, preparations and additives to the order and specification of others for use in the manufacture of pharmaceuticals, medicines, supplements and cosmetics; custom manufacture pharmaceuticals, of medical preparations, of medicines, of food supplements and of cosmetics; none of the foregoing services involving cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basisACTIVE—
042Scientific and technological services, namely, technological services in the nature of computer software design and development, computer technology consulting services, scientific investigations for medical purposes, conducting scientific feasibility studies, scientific research in the field of chemistry and chemical engineering, and formulation of pharmaceuticals, chemical and pharmaceutical analytical services; medical and pharmacological research services; research of foodstuffs; cosmetic research; development of pharmaceutical, medical and cosmetic preparations and of food; quality control for others for pharmaceutical, medical and cosmetic preparations and of food; quality evaluation of pharmaceutical, medical and cosmetic preparations and of food; quality control for others; certification, namely quality control for others; quality control of raw materials; research services in the field of medicine, pharmacy and cosmetics; scientific research in the field of pharmacy; scientific research for medical purposes; scientific research relating to cosmetics; scientific laboratory services; medical research; chemical analysis; none of the foregoing services involving cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 27, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 27, 2024FIMPFINAL DISPOSITION PROCESSED—
Mar 19, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 19, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 19, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 3, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 3, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 13, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 13, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 13, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 28, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Aug 28, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 28, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 28, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 25, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 5, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 26, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2022RFNTREFUSAL PROCESSED BY IB—
Nov 1, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 30, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2022RFNTREFUSAL PROCESSED BY IB—
Apr 22, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 22, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 21, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 20, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2022DOCKASSIGNED TO EXAMINER—
Feb 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance